Table of Content - Neostigmine Methylsulfate Injection Market

Neostigmine methylsulfate injection is a cholinesterase inhibitor that is used as an adjunct in the treatment of myasthenia gravis and as an antidote in the treatment of non-depolarizing neuromuscular blocking agent toxicity in the operating room or intensive care unit setting. It acts by inhibiting the acetylcholinesterase enzyme, which normally breaks down the neurotransmitter acetylcholine at the neuromuscular junction. By inhibiting this enzyme, neostigmine methylsulfate prolongs the actions of acetylcholine, increasing neuromuscular transmission and muscle strength. It helps in the management of myasthenia gravis symptoms such as weakness of the skeletal muscles of the extremities, trunk, throat, and eyes. In overdose or sensitive patients, it can cause increased stimulation at the neuromuscular junction and produce side effects such as nausea, increased saliva, and muscle cramps.

Market Dynamics:

The increasing geriatric population will continue to fuel the growth of the global neostigmine methylsulfate injection market over the forecast period. The elderly are more susceptible to neurological conditions like myasthenia gravis, which frequently needs to be treated with injections of neostigmine methylsulfate. Rising medical expenditures will also continue to fuel the growth of the global neostigmine methylsulfate injection market over the forecast period. The growth of veterinary medicine will create new opportunities for the global neostigmine methylsulfate injection market over the forecast period. Injections of neostigmine methylsulfate are also employed in veterinary medicine, particularly for the treatment of a few neuromuscular diseases in animals. It may open up new commercial prospects to increase the use and availability of neostigmine methylsulfate injections in the veterinary industry.

Lack of knowledge and diagnosis is expected to hamper the growth of the global neostigmine methylsulfate injection market over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global neostigmine methylsulfate injection market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neostigmine methylsulfate injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Baxter International Inc., Pfizer Inc., Fresenius Kabi AG, Boehringer Ingelheim GmbH, Mylan N.V., Novartis International AG, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Sandoz (a division of Novartis), Accord Healthcare Inc., Lannett Company, Inc., Mallinckrodt Pharmaceuticals, and Lupin Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neostigmine methylsulfate injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neostigmine methylsulfate injection market

Detailed Segmentation:

Global Neostigmine Methylsulfate Injection Market, By Dosage:
- 1 mg/mL
- 0.5 mg/mL
Global Neostigmine Methylsulfate Injection Market, By Indications:
- Myasthenia Gravis
- Reversal of Neuromuscular Blockade
Global Neostigmine Methylsulfate Injection Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Neostigmine Methylsulfate Injection Market, By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Global Neostigmine Methylsulfate Injection Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Baxter International Inc.
- Pfizer Inc.
- Fresenius Kabi AG
- Boehringer Ingelheim GmbH
- Mylan N.V.
- Novartis International AG
- Teva Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- GlaxoSmithKline plc
- Sun Pharmaceutical Industries Ltd.
- Sandoz (a division of Novartis)
- Accord Healthcare Inc.
- Lannett Company, Inc.
- Mallinckrodt Pharmaceuticals
- Lupin Limited

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Neostigmine Methylsulfate Injection Market, By Dosage
  - Neostigmine Methylsulfate Injection Market, By Indication
  - Neostigmine Methylsulfate Injection Market, By Distribution Channel
  - Neostigmine Methylsulfate Injection Market, By End User
  - Neostigmine Methylsulfate Injection Market, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
    - Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
  - Restraints
    - Lack of knowledge and diagnosis
  - Opportunities
    - Growth of veterinary medicine
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Neostigmine Methylsulfate Injection Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Neostigmine Methylsulfate Injection Market, By Dosage, 2018-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 - 2030
  - Segment Trends
- 1 mg/mL
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- 0.5 mg/mL
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Global Neostigmine Methylsulfate Injection Market, By Indication, 2018-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 - 2030
  - Segment Trends
- Myasthenia Gravis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Reversal of Neuromuscular Blockade
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Global Neostigmine Methylsulfate Injection Market, By Distribution Channel, 2018-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 - 2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Global Neostigmine Methylsulfate Injection Market, By End User, 2018-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 - 2030
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Specialty Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Ambulatory Surgical Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Global Neostigmine Methylsulfate Injection Market, By Region, 2018-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Region 2019 - 2030
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East & Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Baxter International Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Fresenius Kabi AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Boehringer Ingelheim GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mylan N.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novartis International AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Hikma Pharmaceuticals PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sun Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sandoz (a division of Novartis)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Accord Healthcare Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Lannett Company, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mallinckrodt Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Lupin Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 44 market data tables and 30 figures on “Global Neostigmine Methylsulfate Injection Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount